Arintra Raises $25 Million for Healthcare Revenue Assurance AI
Arintra raised $25 million in Series B funding led by Define Ventures, bringing its total funding to $51 million, the company announced in a press release. Existing investors Peak XV Partners, Yale New Haven Health Center for Health Care Innovation, Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Ten13, and Spider Capital also participated.
The San Francisco company sells an enterprise AI platform for healthcare revenue assurance. Its platform uses agentic AI for medical coding, clinical documentation intelligence, denial appeals, payer insights, and DRG validation across ambulatory, emergency, diagnostic, and inpatient care settings.
Arintra said its platform processes more than $5 billion in annual claim value for healthcare enterprises representing over $50 billion in combined net patient revenue. The company lists UC Davis Health, Mercyhealth, Meritus Health, Rochester Regional Health, Reid Health, and Mercy Medical Center among its customers.
The company said it will use the funding to expand across more enterprise health systems, add clinical and specialty coverage, and extend the platform to additional revenue cycle functions.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
More from: Funding
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more